AKT1 and triple-negative breast carcinoma: As a tumor suppressor, the micro-peptide CIP2A-BP, encoded by LINC00665, can inhibit PI3K/AKT/NFκB signal transduction, thereby limiting the migration and invasion of triple-negative breast cancer cells [5].